EPISODE · Feb 14, 2023 · 9 MIN
THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.
from Answers from the Lab · host Mayo Clinic Laboratories
(00:31):Before we get started, can you tell us a little bit about yourselves and your backgrounds?(02:35):Can you guys give us a brief overview of this assay and what will be changing to characterize marijuana use?(04:28):So which patients should have this testing and when would you say it should be performed, Dr. Langman?(05:58):Are there other test options available and if, and if so, how do these compare?(07:03):This is really the best way to accurately characterize marijuana use. Would you say that's true?(07:11):And then could you, Dr. Langman, explain how the results are used in patient care?
What this episode covers
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ innovative new assay to detect marijuana, or cannabis, use. Using high-resolution, tandem mass spectrometry, our test identifies metabolites of both delta-9- tetrahydrocannabinol (THC) and delta-8 THC, which are psychoactive compounds found in cannabis plants. Our assay is among the only available tests in the nation to detect for delta-8 THC, which is synthesized from hemp plants and increasing in popularity following 2018 legislation that legalized the compound in most states.
NOW PLAYING
THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m